Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'

Clin Exp Dermatol. 2023 Mar 22;48(4):396-397. doi: 10.1093/ced/llac130.

¹ Section of Dermatology, Department of Clinical Medicine and Surgery and Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
² Pathology Unit, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
³ Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
⁴ Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.

No abstract available

Publication types